Categories
News

Pharmaceutical Robots Market Report Insights, Forecast, Share Analysis – Kawasaki Heavy Industries, Ltd, FANUC CORPORATION, KUKA AG

This Pharmaceutical Robots Market business report profoundly attempts to determine the impact of buyers, substitutes, new entrants, competitors and suppliers on the market. The report has explained in-depth market insights about market size, latest trends, market threats and key drivers driving the market. This market research document also supports to secure economies in the distribution of products and find out the best way of approaching the potential. The Pharmaceutical Robots Market study report is evaluated mainly on two segments namely types and applications which cover all the analytical data for current and future markets.

Global Pharmaceutical Robots Market is expected to rise from its initial estimated value of USD 82.85 million to an estimated value of USD 227.36 million by 2026, registering a CAGR of 13.45% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing demand of robots for increased packaging efficiency

Click to Get “Global Pharmaceutical Robots Market” Research Sample PDF Copy Here @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-pharmaceutical-robots-market

Few of the major competitors currently working in the pharmaceutical robots market are Kawasaki Heavy Industries, Ltd, FANUC CORPORATION, KUKA AG, Mitsubishi Electric Corporation, ABB, DENSO CORPORATION, Seiko Epson Corporation, Marchesini Group S.p.A., Universal Robots, YASKAWA ELECTRIC CORPORATION., SHIBUYA CORPORATION, Krones AG, Remtec Automation, LLC and Robert Bosch GmbH.

Global Pharmaceutical Robots Market

By Type (Traditional Robots, Collaborative Pharmaceutical Robots),

By Applications (Picking and Packaging, Inspection of Pharmaceutical Drugs, Laboratory Applications),

By End- User (Pharmaceutical companies, Research laboratories),

By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Market Definition:

Automated machines are widely used in pharmaceutical industry so that work can be done faster and quicker. These machines provide accurate and precise results with zero rates of error.  Pharmaceutical robots are very useful in packaging and transferring of materials like diagnostics kits and essays. These machines also assist the drug manufacturer in research activities related to drug discovery, development and inspection.

Market Drivers:

  • Increasing demand for personalized packaging among consumer is driving market
  • Rising awareness of robotic system in pharmaceutical industry.

Market Restraints:

  • Increasing investment cost is restraining market.
  • Lack of skilled and trained professional is another major factor restraining the growth.

Segmentation:

  • By Type
    • Traditional Robots
      • Articulated Robots
      • SCARA Robots
      • Delta/Parallel Robots
      • Cartesian Robots
      • Other Robots
    • Collaborative Pharmaceutical Robots
  • By Applications
    • Picking and Packaging
    • Inspection of Pharmaceutical Drugs
    • Laboratory Applications
  • By End- User
    • Pharmaceutical companies
    • Research laboratories
  • By Geography
    • North America
      • US
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
      • Russia
      • Turkey
      • Belgium
      • Netherlands
      • Switzerland
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • South Korea
      • India
      • Australia
      • Singapore
      • Thailand
      • Malaysia
      • Indonesia
      • Philippines
      • Rest of Asia Pacific
    • Middle East & Africa
      • South Africa
      • Egypt
      • Saudi Arabia
      • United Arab Emirates
      • Israel
      • Rest of Middle East & Africa

Enquire for customization in Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-pharmaceutical-robots-market

Key Developments in the Market:

  • In January 2017, UAE announced the launch of their first robot pharmacy that will prescribe the medication just in click of the button. It can dispense up to 12 prescriptions in less than a minute and it will be paper free process as the robot will save automatically as soon as doctor documents it automatically.
  • In October 2018, OMRON Corp. has announced the launch of TM series collaborative robot family in 40 countries to provide them moderate working environment. . This machine will have some common solutions like picking, packing, and screw driving. OMRON will also release a “mobile-compatible” model which can convert into LD series autonomous mobile robots.

Competitive Analysis:

Global pharmaceutical robots market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of pharmaceutical robots market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report:

  • Current and future of global pharmaceutical robots market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Table of Content: Global Pharmaceutical Robots Market

Part 01: Executive Summary

Part 02: Scope of The Report

Part 03: Global Pharmaceutical Robots Market Landscape

Part 04: Global Pharmaceutical Robots Market Sizing

Part 05: Global Pharmaceutical Robots Market Segmentation By Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers And Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

And More…..Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-pharmaceutical-robots-market

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]

Categories
News

LATEST NEWS: COVID-19 Impact on Personalized Cancer Vaccines Market Report Insights, Forecast, Share Analysis – Neon Therapeutics, Moderna, Inc., Gritstone Oncology

The Personalized Cancer Vaccines Market report has been produced with the systematic gathering and analysis of information about individuals or organizations conducted through social and opinion research. This wide-reaching Personalized Cancer Vaccines Market advertising report comprises of all the organization profiles of the key players and brands. With the studies, insights and analysis mentioned in the report, comprehensible idea about the marketplace can be obtained with which business decisions can be taken quickly and easily. This document is a detailed portrayal of the market scenarios which introduces a mix of research mastery and business methodologies. Every possible effort has been taken into account while investigating and scrutinizing data to set up this Personalized Cancer Vaccines Market research report.

The major competitors currently working in the personalized cancer vaccines market: Neon Therapeutics, Moderna, Inc., Merck & Co., Inc., Gritstone Oncology, Personalis Inc, Genocea Biosciences, Inc., F. Hoffmann-La Roche Ltd, CureVac AG, Celldex Therapeutics, BioNTech SE, Advaxis, Inc, and among others.

Get a sample copy of report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-personalized-cancer-vaccines-market

Personalized Cancer Vaccines Market to grow with a substantial CAGR in the forecast period of 2019-2026 Growing rate of prevalence rate of cancer and accelerating demand of novel therapies to prevent of cancer related disorders are the key factors for lucrative growth of market.

Global Personalized Cancer Vaccines Market

By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Cervical Cancer, Glioblastoma),

By Mechanism of action Type (Tumor-associated antigens (TAAs), Tumor-specific antigens (TSAs), Somatic Mutations in Cancer Pharmacogenomics, Pharmacogenomics towards Genomic Polymorphism),

By Biomaker Type (Pharmacogenomic, Prognostic and Predictive Biomarkers, Immune Checkpoint Biomarkers and Others),

By therapy Type (Immunotherapy),

By Route of Administration (Injectabls),

By End- users (Hospitals, Homecare, Specialty Clinics, Others),

By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Market Definition: Global Personalized Cancer Vaccines Market

Personalized cancer vaccines are the type of immunotherapy that boosts the immune system to fight against a cancerous cell. These types of vaccine are tailored to match a patient’s particular tumor cell after received cancer related surgery. This vaccine may prevent from cancer, destroy cancer cells and inhibit the growth of tumors cells.

According to the article published in The American Cancer Society, it was identified that the total incidence of cancer in the United States in the year 2018 were1, 735,350 and  609,640 patients die from cancer in the same year. Growing rate of incidence rate of cancer and accelerating demand of novel therapies to prevent of cancer related disorders are the key factors for lucrative growth of market.

Market Drivers

  • Increases cases of cancer globally
  • Growing demand of personalized cancer vaccine production
  • Government initiatives and assistance for cancer related preventions
  • Robust pipeline of novel therapies under clinical development
  • Increase in strategic collaboration between the companies

Market Restraints

  • High cost involved in the treatment
  • Scientific and major technical challenges for production of personalized cancer vaccine
  • Inadequate awareness about personalized cancer vaccine in some developing countries

Make an Inquiry Before Buying @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-personalized-cancer-vaccines-market

Segmentation: Global Personalized Cancer Vaccines Market

By Cancer Type

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Leukemia
  • Prostate Cancer
  • Cervical Cancer
  • Glioblastoma
  • Other

By Mechanism of action Type

  • Tumor-associated antigens (TAAs)
  • Tumor-specific antigens (TSAs)
  • Somatic Mutations in Cancer Pharmacogenomics
  • Pharmacogenomics towards Genomic Polymorphism

By Biomaker Type

  • Pharmacogenomic Biomarkers
  • Prognostic and Predictive Biomarkers
  • Immune Checkpoint Biomarkers
  • Others

By Route of administration

  • Injectables

 By End users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific
  • Middle East & Africa
    • South Africa
    • Egypt
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Rest of Middle East & Africa

Key Developments in the Market:

In March 2019, Neon Therapeutics, Inc. investigating NEO-PV-01, a novel personalized cancer vaccine cells in a combination with nivolumab that targeting neoantigens and kills their cancer cells.

In September 2016, BioNTech AG and Genentech, Inc. has entered into research collaboration for the development of messenger RNA (mRNA)-based, individualized cancer vaccines for the treatment of broad range of cancer. As per the deal, BioNTech AG receive USD 310 million as a upfront payment and eligible to receive milestone payment.

In June 2016, Moderna, Inc and Merck & Co., Inc entered into research collaboration for the development of mRNA-based personalized cancer vaccines in a combination with keytruda (pembrolizumab) for the treatment of multiple types of tumor. As per the deal, Moderna, Inc. will receive USD 200 million from Merck & Co., Inc. as upfront payment.

Competitive Analysis: 

Global personalized cancer vaccines market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of personalized cancer vaccines market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of Global Personalized Cancer Vaccines Market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-personalized-cancer-vaccines-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]

Categories
News

Peripheral Intravenous (IV) Catheter Market Report Insights, Forecast, Share Analysis – Smiths Medical, STENTYS SA, VOGT MEDICAL

This Peripheral Intravenous (IV) Catheter Market report has several topics including market trend analysis, market drivers, market restraints, opportunities, threats, application analysis, emerging markets, and futuristic market scenario. Moreover, it analyses industry by product type, by equipment type, by price category e.g. discount, mainstream, or premium etc., by distribution channel, by application and by geography. All the numerical data included in the report is backed up by excellent tools such as SWOT analysis, Porter’s Five Forces Analysis and others. Analytical study of this Peripheral Intravenous (IV) Catheter Market document aids in mapping growth strategies to increase sales and build brand image in the market.

The Global Peripheral Intravenous (IV) Catheter Market is expected to reach USD 6.73 billion by 2025, from USD 4.03 billion in 2017 growing at a CAGR of 6.1% during the forecast period of 2018 to 2025.

Some of the major players operating in the market are B. Braun Melsungen, BD, C.R. Bard, Smiths Medical, STENTYS SA, VOGT MEDICAL, Terumo CorporationAngioDynamics, RenovoRx, Retractable Technologies, intra special cathers, RAYS health and safety, Teleflex, Vigmed and Vygon, ISO-MED, among others.

Download exclusive PDF sample report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-peripheral-intravenous-iv-catheter-market

Global Peripheral Intravenous (IV) Catheter Market,

By Product Type (Short PIVC, Integrated/Closed PIVC),

By Technology (Short Peripheral Intravenous Catheter, Ported Peripheral Intravenous Catheter, Non-ported Peripheral Intravenous Catheter, Integrated/Closed Peripheral Intravenous Catheter),

By End Users,

By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends and Forecast to 2025

Major Market Drivers and Restraints:

  • Increase in number of hospitalizations
  • Increasing popularity of integrated/closed peripheral intravenous catheters
  • Increased adoption of safety ported short peripheral intravenous catheters
  • Increased implementation of product bundling strategy
  • Complications associated with peripheral intravenous catheters (PIVCs)

Definition of Global Peripheral Intravenous (IV) Catheter Market:

The peripheral intravenous catheter (PIVC) is a small flexible tube. This is inserted into a peripheral vein for the delivery of medicines and nutritional supplements. It is widely helpful in the collection of blood samples for diagnostic purpose. The peripheral intravenous catheters can be divided into two types, short peripheral intravenous catheters (PIVCs) and integrated/closed catheters (PIVCs). Once the catheter is in place, the Peripheral intravenous catheters can be removed. This is inserted into the patient’s body using a needle. After this process is done the peripheral intravenous catheter is attached to the patient skin by using medical adhesive tape. In 2014, about 20.0 million people visited physicians’ offices with the detection of cancer as the primary diagnosis, 17.8 million people visited physicians’ offices, and 3.9 million people visited hospital outpatient departments due to infectious and parasitic diseases in the US. According to the Centers for Disease Control and Prevention (CDC), in 2014, there were 141.4 million emergency department visits which further resulted in 11.2 million hospital admissions and 1.8 million critical care unit admissions in the US. This showed that the people of US had one or more chronic health conditions.

Download Detailed TOC @ http://databridgemarketresearch.com/toc/?dbmr=global-peripheral-intravenous-iv-catheter-market

Segmentation of Global Peripheral Intravenous (IV) Catheter Market:

Based on product type:

  • Short Peripheral Intravenous Catheter
  • Ported Peripheral Intravenous Catheter
  • Non-Ported Peripheral Intravenous Catheter
  • Integrated/Closed Peripheral Intravenous Catheter.

On the basis of technology:

  • Conventional Peripheral Intravenous Catheter
  • Safety Peripheral Intravenous Catheter

On the basis of end users:

  • Hospitals
  • Ambulatory Centers
  • Clinics
  • Community Healthcare
  • Others

Based on geography:

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.

Order a Copy of Global Peripheral Intravenous (IV) Catheter Market Report @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-peripheral-intravenous-iv-catheter-market

Frequently Asked Questions:

  • What will the market size be in 2025?
  • What are the key factors driving the global market?
  • What are the challenges to market growth?
  • Who are the key players in the market?
  • What are the market opportunities and threats faced by the key players?
  • What will be the growth rate in 2025?
  • Which strategies are used by top players in the Global Peripheral Intravenous (IV) Catheter Market?

Competitive Analysis of Global Peripheral Intravenous (IV) Catheter Market:

The global peripheral intravenous (IV) catheter market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of peripheral intravenous (IV) catheter market for global, Europe, North America, Asia Pacific and South America.

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]

Categories
News

PCR Devices Market Report Insights, Forecast, Share Analysis – Abbott, BD, F. Hoffman-La Roche Ltd, QIAGEN

To make this PCR Devices Market business report of supreme quality, consistent efforts of an enthusiastic, innovative dynamic and skilled researchers and analysts have been utilized. The document provides key measurements, status of the manufacturers and is a significant source of direction for the businesses and organizations. Market parameters covered here include but are not limited to latest trends, market segmentation, new market entry, industry forecasting, target market analysis, future directions, opportunity identification, strategic analysis, insights and innovation. The PCR Devices Market report endows with historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry.

Few of the major competitors currently working in the PCR devices market are Abbott. (US), BD(US), F. Hoffman-La Roche Ltd (Switzerland), QIAGEN ( Germany), Thermo Fisher Scientific Inc.(US), Bio-Rad Laboratories, Inc. (US), Agilent Technologies, Inc. (US), Danaher (US), Takara Bio, Inc (Japan), Biomérieux S.A. (France), Fluidigm (US), Merck KGaA (Germany), Promega Corporation (US), Analytik Jena AG (Germany), SYGNIS Pharma AG(Germany ), LGC Limited (UK), Siemens (Germany), Enzo Life Science, Inc (India) RainDance Technologies, Inc (US) Affymetrix Inc  (US )among others

Get Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-pcr-devices-market

Global PCR Devices Market is expected to rise from its initial estimated value of USD 2.85 billion in 2018 to an estimated value of USD 5.68 billion by 2026, registering a CAGR of 9.00% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing usage of biomarkers for diagnosis of diseases.

Global PCR Devices Market

By Technology (Digital PCR, Real-time PCR),

By Product Type (Instrument, Reagent, Consumables, Others),

By Application (Oncology, Blood Testing, Pathogen Detection, Research, Forensic, Others),

By End User (Hospital, Diagnostic Center, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Academia, Laboratories),

By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

PCR devices have its applications in DNA sequencing, cloning, library generations, mutagenesis, expression profiling among others. PCR devices are thermal cycler which is commonly used in laboratories for amplifying the segments of DNA through polymerase chain reaction.

According to World Health Organization, Globally a third of ischaemic heart disease is attributable to high cholesterol. Overall, raised cholesterol is estimated to cause 2.6 million deaths (4.5% of total) and 29.7 million disability in 2008 This significant number is expected to act as a driver to the market growth.

Market Drivers

  • There is rise in incidences of infectious diseases and genetic disorders infants are expected to act as a driver to the market growth.
  • There is increase in usage of biomarkers for diagnosis of diseases infants is also expected to act as a driver to the market growth.
  • Technological advancement to adopt the new technology in PCR devices infants is also expected to act as a driver to the market growth.

Market Restraints

  • High amount of costing of these equipment is expected to act as a restraint to the market growth
  • Lack of knowledge and skilled professionals is expected to act as a restraint to the market growth.

Segmentation: Global PCR Devices Market

By Technology

  • Digital PCR
  • Real-time PCR

By Product Type

  • Instrument
  • Reagent
  • Consumables
  • Others

By Application

  • Oncology
  • Blood Testing
  • Pathogen Detection
  • Research
  • Forensic
  • Others

By End User

  • Hospital
  • Diagnostic Center
  • Pharmaceutical
  • Biotechnology
  • Clinical Research Organizations
  • Academia
  • Laboratories

By Geography

  • North America
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific
  • Middle East & Africa
    • South Africa
    • Egypt
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Rest of Middle East & Africa

Request for Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-pcr-devices-market

Key Developments in the Market:

  • In April 2019, Thermo Fisher launches ‘smart’ PCR systems this is equipped with facial unlock systems that can work on voice commands. This will simplify the process as many researchers in the lab perform experiments while wearing gloves.
  • In Jan, 2019, Qiagen acquired Formulatrix’s Digital PCR, TB Testing, Informatics products. With this acquisition Qiagen is focusing on Digital PCR which is not yet addressed properly.

Competitive Analysis:

Global PCR devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of PCR devices market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

  • Current and future of global PCR devices market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Order a Copy of This Research Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-pcr-devices-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]

Categories
News

Patient Positioning System Market Report Insights, Forecast, Share Analysis – Applications, Trends And Forecasts To 2024

Patient Positioning System Market research report consists of latest, comprehensive and most up-to-date market information and precious data. SWOT analysis and Porter’s Five Forces Analysis are the two constantly and favorably employed tools for generating this report. Besides this, it categorizes the breakdown of global data by manufacturers, region, type, and application, and also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, and distributors. This Patient Positioning System Market document is very consistent as all the data and information regarding the Medical Devices industry is collected via genuine sources such as websites, journals, annual reports of the companies, and magazines.

The Global Patient Positioning System Market accounted to USD 987.5 million in 2016 growing at a CAGR of 4.7% during the forecast period of 2017 to 2024.

Some of the major players operating in global patient positioning system market are Hill-Rom (U.S.),STERIS Plc. (U.S.), Getinge AB (Sweden),Stryker (U.S.),Span-America (U.S.),Elekta AB (Sweden),SKYTRON (U.S.),Mizuho OSI (U.S.), LEONI AG (Germany), C-RAD (Sweden), Alvo (Poland), Civco Radiotherapy (U.S.), Eschmann Equipment (U.K.), GE Healthcare (U.K.), Meditek (Canada) and Innovative Medical Products Inc. (U.S.) among others.

Download exclusive PDF sample report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-patient-positioning-system-market

Global Patient Positioning System Market, By Product, {Tables (Surgical Tables, Radiolucent Imaging Tables), Accessories}, Application (Surgery, Cancer Therapy, Disease Diagnosis), and End User (Hospitals, Ambulatory Surgery Center), Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast

Definition: Global Patient Positioning System Market

The patient positioning system market executes the performance,encasing an in-depth judgment of the market state and competitive landscape.The growth is due to a great extent of the developing needs of current medicinal services. The entire medical equipment market is facing and confronting different new challenges. The patient positioning market is specifically connected with the modernization drives which are directly flooding the healthcare canvas. Few modest modernization drives have started with great new innovation, standards creation and streamlined the entire post and presurgery care for whole diagnostic industry which is evolving faster around the world. It creates an advantage point for both patients and doctors. It diminishes pain and invigorates the curing procedure and wide assortment of these mechanical assemblies is accessible in the market.

Major Market Drivers and Restraints:

  • Rise in geriatric population
  • Increase in competitive landscape
  • Technological advancement
  • Growth in hospitals investment for upgradation
  • Risk in patient safety issues

Segmentation: Global Patient Positioning System Market

  • On the basis of product type, global patient positioning system market is segmented into tables and accessories. Tables are further sub segmented into surgical tables, radiolucent imaging tables. The surgical tables segment accounted for the largest market share in 2016 due to technological advancements in tables and rising awareness towards image guided surgeries.
  • On the basis of application, global patient positioning system market is segmented into surgery, cancer therapy and disease diagnosis. The surgery segment accounted the largest market share in the market in 2016 but disease diagnosis segment is expected to grow in the forecast period due to increasing prevalence of chronic diseases such as cancer and cardiovascular diseases.
  • On the basis of end user, global patient positioning system market is segmented into hospitals and ambulatory surgery center.
  • On the basis of geography, global patient positioning system market report covers data points for 28 countries across multiple geographies such as North America, South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the global patient positioning system market.

Competitive Analysis : Global Patient Positioning System Market

The Global Patient Positioning System Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes patient positioning system market shares for global, Europe, North America, Asia Pacific and South America.

Research Methodology: Global Patient Positioning System Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or drop down your inquiry.

Demand Side Primary Contributors: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

To Buy Complete Report Click Here @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-patient-positioning-system-market

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]

Categories
News

Patient Portal Market Report Insights, Forecast, Share Analysis – Allscripts Healthcare, LLC, Athenahealth, Cerner Corporation, eClinicalWorks

The Patient Portal Market report includes all the company profiles of the major players and brands. This market analysis covers noteworthy information which makes the entire report a convenient asset for administrators, investigators, industry specialists, and other key individuals. This market analysis report comprises of a number of market dynamics and estimations of the growth rate and the market value based on growth inducing factors. Being an outstanding resource of market info, the Patient Portal Market report provides recent as well as upcoming technical and financial details of the industry to 2026.

Some of the major competitors currently working in the global patient portal market are Allscripts Healthcare, LLC; Athenahealth, Cerner Corporation, eClinicalWorks, CureMD Corporation, NXGN Management, LLC, Greenway Health, LLC, Medfusion Inc, ZH Healthcare, Inc., CompuGroup Medical, Greenway Health, LLC, Hello Health Inc., GENERAL ELECTRIC COMPANY, McKesson Corporation, Valley Health System., Saint Francis Healthcar, Southwest Care Centers, Adelante Healthcare., ViSolve Inc., IQVIA, among others.

Download exclusive PDF sample report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-patient-portal-market

Global Patient Portal Market is set to witness a healthy CAGR of 17.02% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing demand for cloud- based patient portal solutions and rising healthcare expenditure are the factors for the growth.

Global Patient Portal Market By Type (Integrated Patient Portals, Standalone Patient Portals), Delivery Mode (Web-Based Delivery, Cloud-Based Delivery), End- User (Providers, Payers, Pharmacies, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026

A patient portal is a safe internet service that offers patients with easy 24-hour access to personal health information from anywhere connected to the Internet. To access a portal, patients are given safe login and password by their physician. These patient portals include information associated with the patient history, recent doctor visit, discharge summaries, chronic disease medication and other. The patient portal consolidates the patient data that enables the health care provider to behave appropriately and provide efficient therapy and monitor the health of the patient. These patient portals are of type’s integrated patient portals and standalone patient portals.

Market Drivers

  • Increasing demand for patient portal among elderly population will drive the growth of this market
  • Rising usage of EHR solutions also uplift the growth of this market
  • Increasing government initiative to increase the adoption patient portal enhances the market growth
  • Rising adoption of patient-centric approach by healthcare payers also contributes as a factor for the growth of this market

Market Restraints

  • Increasing data privacy and security concerns will restrict this market growth
  • High investment cost will also hamper the growth of the market
  • Growing requirement of infrastructural investments to support patient portals is another factor impeding this market growth

Segmentation: Global Patient Portal Market

By Type

  • Integrated Patient Portals
  • Standalone Patient Portals

By Delivery Mode

  • Web-Based Delivery
  • Cloud-Based Delivery

By End- User

  • Providers
  • Payers
  • Pharmacies
  • Others

By Geography

  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • Italy
    • UK.
    • France
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Turkey
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Rest of South America
  • Middle East and Africa
    • South Africa
    • Rest of Middle East and Africa

To Enquire Regarding This Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-patient-portal-market

Key Developments in the Market:

  • In August 2019, IQVIA announced the launch of their new IQVIA Patient Portal which is specially designed so they can increase the recruitment, involvement and retention of patients in clinical trials by ensuring transparency and cooperation before, during and after clinical trials. The Patient Portal of IQVIA boosts patient understanding and interaction during the trial and decreases the massive costs associated with patients dropping out of the trial or unavailable for follow-up
  • In October 2018, Intelerad Medical Systems announced the launch of their new patient portal solution nuage Patient Portal which will allow imaging suppliers to embolden their patients with smooth, self-service access to their history of examination, pictures and reports, as well as the capacity to secure access for anyone. It offers an easy-to-use, convenient choice to enable patients with healthcare data possession and personalized medicine experience

Competitive Analysis:

Global patient portal market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of patient portal market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

  • Current and future of global patient portal market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Download Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-patient-portal-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]

Categories
News

Patient Handling Equipment Market Coronavirus (COVID-19) Impact Analysis With Concentrate On Key Drivers, Trends & Challenges 2019-2026

Patient Handling Equipment Market report is prepared with the detailed market analysis performed by a team of industry experts, skillful analysts, dynamic forecasters and knowledgeable researchers. This market research report is one-stop archive for in-depth knowledge of market analytics aggregated by a broad rundown of distributors from over the globe. The report incorporates well-researched data sources that empower clients to focus upon current market opportunities and shield against credible dangers predominant in the market in the ebb and flow situation. The thorough market analysis covered in this Patient Handling Equipment Market report by proficient experts gives every bit of knowledge which is imperative to design and align with current market scenarios.

Some of the prominent participants operating in this market are OpeMed Ltd., Vendlet ApS, V. Guldmann A/S, DJO LLC, Hill-Rom Services Inc, Invacare Corporation, Etac AB, Permobil, Joerns Healthcare LLC, Handicare, Stiegelmeyer GmbH & Co. KG, Stryker, Sunrise Medical LLC, LINET, Arjo, Mangar Health, Benmor Medical Limited, PARAMOUNT BED CO., LTD., Drive DeVilbiss Sidhil Ltd., Medline Industries, Inc.

Ask for a Sample Copy of Global Patient Handling Equipment Market Report: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-patient-handling-equipment-market

Global Patient Handling Equipment Market By Mode (Mechanical Equipment, Non Mechanical Equipment), Product Type (Medical Beds, Patient Repositioning Equipment, Mobility Aid, Bathroom Safety and Ambulatory Aids), Type of Care (Long Term Care, Bariatric Care, Acute and Critical Care, Wound Care, Fall Prevention and Others), Accessories (Hospital Bed Accessories, Medical Bed Accessories, Lifting Accessories, Transfer Accessories, Stretcher Accessories and Others), End User ( Hospital, Home Care Settings, Elderly Care Facilities and Others), Geography (North America, Europe, Asia Pacific, Middle East & Africa and South America ) – Industry Trends and Forecast to 2026

Global patient handling equipment market is projected to register a healthy CAGR of 10.6% in the forecast period of 2019 to 2026.

International Patient Handling Equipment Market report has been formed with the systematic gathering and estimation of market information for Medical Devices industry. All this information is supplied in such a form that properly gives explanation of various facts and figures to the business. The market data described in the report helps to make out diverse market opportunities present worldwide for Medical Devices industry. This report endows with accurate information about market trends, industrial changes, and consumer behavior etc. Taking up such market research report is always gainful for any company whether it is a small scale or large scale, for marketing of products or services. Analytical study of this Global Patient Handling Equipment Market report supports in mapping growth strategies to increase sales and build brand image in the market.

Segmentation: Global Patient Handling Equipment Market

By Mode (Mechanical Equipment, Non Mechanical Equipment),

By Product Type (Medical Beds, Patient Repositioning Equipment, Mobility Aid, Bathroom Safety and Ambulatory Aids),

By Type of Care (Long Term Care, Bariatric Care, Acute and Critical Care, Wound Care, Fall Prevention and Others),

By Accessories (Hospital Bed Accessories, Medical Bed Accessories, Lifting Accessories, Transfer Accessories, Stretcher Accessories and Others),

By End User (Hospital, Home Care Settings, Elderly Care Facilities and Others),

By Geography (North America, Europe, Asia Pacific, Middle East & Africa and South America) – Industry Trends and Forecast to 2026

For discount, click here: https://www.databridgemarketresearch.com/request-a-discount/global-patient-handling-equipment-market

Table of Contents:

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY 1.2 MARKET DEFINITION 1.3 OVERVIEW OF THE GLOBAL PATIENT HANDLING EQUIPMENT MARKET 1.4 CURRENCY AND PRICING 1.5 LIMITATIONS 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED 2.2 GEOGRAPHIC SCOPE 2.3 YEARS CONSIDERED FOR THE STUDY 2.4 CURRENCY AND PRICING 2.5 RESEARCH METHODOLOGY 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 2.7 DBMR MARKET POSITION GRID 2.8 MARKET APPLICATION COVERAGE GRID 2.9 THE CATEGORY VS TIME GRID 2.10 DBMR MARKET CHALLENGE MATRIX 2.11 DBMR VENDOR SHARE ANALYSIS 2.12 MULTIVARIATE MODELING 2.13 PRODUCT TIMELINE CURVE 2.14 SECONDARY SOURCES 2.15 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 RISING GERIATRIC POPULATION 3.1.2 INCREASING PREVALENCE OF CHRONIC DISEASES 3.1.3 EMERGENCE OF TECHNOLOGICAL ADVANCED PRODUCTS

3.2 RESTRAINTS:

3.2.1 HIGH COST OF ADVANCED WHEELCHAIRS 3.2.2 LACK OF PROFESSIONALS HAVING ACCESS TO TECHNOLOGY

3.3 OPPORTUNITIES

3.3.1 HIGH RISK OF MUSCULOSKELETAL INJURIES TO CAREGIVERS 3.3.2 INCREASING UNMET MEDICAL NEEDS IN DEVELOPING COUNTRIES

3.4 CHALLENGES

3.4.1 DIFFICULTIES IN HANDLING BARIATRIC PATIENTS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 KEY PRIMARY INSIGHTS

7 GLOBAL PATIENT HANDLING EQUIPMENT MARKET, BY MODE

8 GLOBAL PATIENT HANDLING EQUIPMENT MARKET, BY PRODUCT TYPE

9 GLOBAL PATIENT HANDLING EQUIPMENT MARKET, BY TYPE OF CARE

10 GLOBAL PATIENT HANDLING EQUIPMENT MARKET, BY ACCESSORIES

11 GLOBAL PATIENT HANDLING EQUIPMENT MARKET, BY END USER

12 GLOBAL PATIENT HANDLING EQUIPMENT MARKET BY GEOGRAPHY

13 GLOBAL PATIENT HANDLING EQUIPMENT MARKET, COMPANY LANDSCAPE

14 COMPANY PROFILES

Reasons for Buying this Report

  1. This Global Patient Handling Equipment Market report provides pin-point analysis for changing competitive dynamics
  2. It provides a forward looking perspective on different factors driving or restraining market growth
  3. It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  4. It helps in understanding the key product segments and their future
  5. It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  6. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments.

Place a purchase order of this report @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-patient-handling-equipment-market

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]

Categories
News

Parkinson’s Disease Market Report Insights, Forecast, Share Analysis – Global Current Trade Size And Future Prospective

Global Parkinson’s Disease Market By Type (Drug-induced parkinsonism, Vascular parkinsonism, Normal pressure hydrocephalus (NSA), Corticobasal degeneration (CBD), Progressive supranuclear palsy (PSP), Multiple system atrophy (MSA), Idiopathic Parkinson’s and Others), Mechanism of Cation type( Dopamine agonists, Monoamine oxidase B (MAO-B) inhibitors, Catechol-O-methyltransferase (COMT) inhibitors, Adenosine A2 receptor antagonist), Therapy Type (Medication, Deep brain stimulation and Others), Drug Type (Amantadine, Safinamide, Brivaracetam, Pimavanserin, Carbidopa and levodopa, Rivastigmine tartrate, Rotigotine, Ferampanel, Apomorphine hydrochloride, Pramipexole and Others), Route of Administration (Oral, Sublingual, Parenteral  and Others), End- users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Few of the major competitors currently working in the global parkinson’s disease market are, Teva Pharmaceutical Industries Ltd, GlaxoSmithKline Plc, Acorda Therapeutics, Inc, Amneal Pharmaceuticals LLC , Imugene Limited,  Immutep, F. Hoffmann-La Roche Ltd, Osmotica Pharmaceuticals plc, Vertical Pharmaceuticals, LLC,  Adamas Pharmaceuticals, Inc, Novartis AG, Eli Lilly and Company, AbbVie Inc  and few among others.

Global Parkinson’s Disease Market is rising gradually to an estimated value of USD 9.7 Billion by 2026 registering a healthy CAGR of 12.2% in the forecast period of 2019-2026. This significant rise in market value can increase research development initiatives to launching novel therapies. Request for Sample Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-parkinsons-disease-market

Global Parkinson’s Disease Market research report takes into consideration several industry verticals such as company profile, contact details of the manufacturer, product specifications, geographical scope, production value, market structures, recent developments, revenue analysis, market shares and possible sales volume of the company. With such data and facts, it becomes easy to have actionable ideas, enhanced decision-making and better mapping business strategies. An all-inclusive data and information of promptly changing market landscape such as what is already present in the market, future trends or market expectations, the competitive environment, and competitor strategies can be obtained from this report. It collectively aids in planning business strategies with which businesses can surpass competitors.

Market Definition: 

Parkinson’s disease is chronic and progressive neurodegenerative disorders that affects dopamine producing neurons in central nervous system. Parkinson’s disease tends to develops in brain over many years. The patient with Parkinson’s disease experience tremor, slow movement, rigid muscle, impaired posture and balance, loss of automatic movements, slurry speech and others.

According to the Clinical Practice Research Data link summary report 2018, it is identified that there were 145,519 prevalence cases of patient with age 20 and above with Parkinson’s disease in UK seen in the year 2018. The estimation incidence cases were 18,461 in patient aged above 45 or over. This significant rise in patient number acts as a driver for the growth of Parkinson’s disease Market.

Market Drivers

  • Increase in prevalence rate of parkinson’s disease worldwide
  • Exposure to certain toxin or change in environment may increase the parkinson’s disease
  • The launch of new products and research collaboration are the prime strategies to reinforce the market position
  • Growing in aging population as it affect most commonly in geriatric population
  • Increase in the rate of R&D initiatives is driving parkinson’s disease drug therapeutics market

Market Restraints

  • High cost involved in the treatment
  • Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth if the market
  • Lack of awareness among the patient and physician about parkinson’s disease treatment

Enquire for customization in Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-parkinsons-disease-market

Segmentation: Global Parkinson’s Disease Market

By Type

  • Drug-induced parkinsonism
  • Vascular parkinsonism
  • Normal pressure hydrocephalus (NSA)
  • Corticobasal degeneration (CBD)
  • Progressive supranuclear palsy (PSP)
  • Multiple system atrophy (MSA)
  • Idiopathic Parkinson’s
  • Others

By Mechanism of Cation type

  • Dopamine agonists
  • Monoamine oxidase B (MAO-B) inhibitors
  • Catechol-O-methyltransferase (COMT) inhibitors
  • Adenosine A2 receptor antagonist

By Drug Type

  • Amantadine
  • Safinamide
  • Brivaracetam
  • Pimavanserin
  • Carbidopa and levodopa
  • Rivastigmine tartrate
  • Rotigotine
  • Ferampanel
  • Apomorphine hydrochloride
  • Pramipexole
  • Others

By Therapy

  • Medication
  • Deep brain stimulation
  • Others

By Route of administration

  • Oral
  • Parenteral
  • Sublingual
  • Others

By End Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Geography

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Key Developments in the Market:

  • In February 2018, Osmotica Pharmaceuticals plc received FDA approval for Osmolex ER (amantadine hydrochloride) which is an extended release tablet indicated for the treatment of parkinson’s disease and drug-induced extrapyramidal reactions in adult patients
  • In August 2017, Adamas Pharmaceuticals, Inc. received FDA approval Gocovri (amantadine) extended release tablet for the treatment of dyskinesia in patients with parkinson’s disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications

Competitive Analysis: Global Parkinson’s Disease Market

Global parkinson’s disease market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of parkinson’s disease market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

  • Current and future of global parkinson’s disease market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level

All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

View Detailed Table of Content @ https://www.databridgemarketresearch.com/toc/?dbmr=global-parkinsons-disease-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]

Categories
News

Over the Counter (OTC) Drugs Market Report Insights, Forecast, Share Analysis – Novartis AG, Sun Pharmaceutical Industries Ltd., Alkem Labs

This Over the Counter (OTC) Drugs Market report provides an overview of the Pharmaceutical industry which is gaining momentum in the last few years. The market report uses a range of steps for collecting, recording, analysing and interpreting market data to make this report all-inclusive. It also offers an overview of the industry that might promote interest among prospective investors, large corporations and everyday users who could participate in the next big opportunity or make their lives just a little easier. The Over the Counter (OTC) Drugs Market report contains the list of leading competitors, strategic industry analysis and the insights of key factors influencing the pharmaceutical industry.

The major competitors currently working in the global over the counter (OTC) drugs market are Johnson & Johnson Services, Inc., Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Sanofi, F. Hoffmann-La Roche Ltd, Bayer AG, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc., Novartis AG, Sun Pharmaceutical Industries Ltd., Alkem Labs, Reckitt Benckiser Group plc., Piramal Enterprises Ltd., , Cipla, Pfizer Inc., Procter & Gamble, Perrigo Company plc, Mylan N.V., DAIICHI SANKYO COMPANY, LIMITED among others.

Click Here To Get Global Over the Counter (OTC) Drugs Market Research Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-over-the-counter-otc-drugs-market

Global Over the Counter (OTC) Drugs Market By Products Type (Analgesics, Cold, Cough & Flu Products, Gastrointestinal Products, Ophthalmic Products, Dermatology Products, Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and  Forecast to 2026

over the counter (OTC) drugs market is rising gradually with a substantial CAGR of 8.7% in the forecast period of 2019-2026. Adoption of OTC drugs by many pharmaceutical companies and usage by general people over prescription drugs brings a great opportunity to the market growth.

Market Definition:

Over The Counter (OTC) drugs are medications that can be taken without the consultation from healthcare professionals by the general public based on the safety and efficacy of the drugs. Some examples of OTC drugs are acetaminophen (paracetamol) and ibuprofen for pain relief, dextromethorphan and cough suppressants. These drugs are safe and effective and are used for the treatment of conditions that do not require the direct consultation of any doctor. OTC drugs are available in all pharmacies and others places such as grocery stores and gas stations.

According to the Consumer Healthcare Products Association, the use of OTCs has given rise to the allergy sufferers from 66% (2009) to 75% (2015). An estimated to 81% of adults prefer to use OTC medications as primary option for minor diseases and conditions.

Market Drivers

  • Favorable regulatory policies and conditions for approval of OTC drugs will boost the market growth in the forecast period
  • Increasing geriatric population which is highly susceptible to several diseases such as joint pain is another factor uplifting the growth of this market
  • Affordable cost associated with OTC drugs is a major driver of market growth
  • Increasing patent expirations of many drugs resulting in use as OTC drugs drives the market growth

Market Restraints

  • Lack of health and OTC products awareness in rural areas is an obstruction to the market growth
  • Incorrect diagnosis results in inappropriate use of OTC drugs acting as restrain to the market growth
  • Competition amongst the existing players is another factor restricting this market growth

Table Of Contents: Global Over the Counter (OTC) Drugs Market

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Pipeline Analysis

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Browse TOC with selected illustrations and example pages of Global Over the Counter (OTC) Drugs Market @ https://www.databridgemarketresearch.com/toc/?dbmr=global-over-the-counter-otc-drugs-market

Segmentation: Global Over the Counter (OTC) Drugs Market

By Products Type

  • Analgesics
  • Cold, Cough & Flu Products
  • Gastrointestinal Products
  • Ophthalmic Products
  • Dermatology Products
  • Others

By End Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Distribution Channels

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • Others

By Geography

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Key Developments in the Market:

  • In July 2019, Sanofi announced an agreement with F. Hoffmann-La Roche Ltd to get the exclusive OTC rights to Tamiflu, an antiviral drug used for the prevention and treatment of patients with influenza or flu. By this agreement, Sanofi will handle the FDA negotiation for the OTC switch and receive the marketing and distribution rights of Tamiflu in the United States
  • In March 2018, GlaxoSmithKline plc purchased 36.5% stake in the Consumer Healthcare Joint Venture from Novartis AG. This agreement provides GlaxoSmithKline plc business of sensodyne toothpaste and over-the-counter pills from Novartis AG. By this deal, GlaxoSmithKline plc will own the OTC business of the company and Novartis AG will be enabled to focus on its core businesses

Competitive Analysis:

Global over the counter (OTC) drugs market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of over the counter (OTC) drugs market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

  • Current and future of global over the counter (OTC) drugs market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Any Questions? Inquire here before the purchase of Over the Counter (OTC) Drugs Market https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-over-the-counter-otc-drugs-market

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact:                                               

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]

Categories
News

Otitis Drug Market Report Insights, Forecast, Share Analysis – Novartis AG, Sanofi, Bristol-Myers Squibb Company

The Otitis Drug Market report has been crafted after a thorough study of various key market segments like market size, latest trends, market threats & key drivers driving the market. This market report recognizes and analyses the emerging trends along with major drivers, challenges and opportunities in the market. It also performs the analysis of the global market share, segmentation, revenue growth estimation and geographic regions of the market. Moreover, the market analysis in this Otitis Drug Market business document consists of competitive study, production information analysis, applications, and region-wise analysis, competitor landscape, consumption and revenue study, cost structure analysis, price evaluation and revenue analysis till 2026.

Few of the major competitors currently working in the global otitis drug market are Eli Lilly and Company, Abbott, GlaxoSmithKline plc, Bayer AG, Novartis AG, Sanofi, Bristol-Myers Squibb Company, Otonomy Inc., Torrent Pharmaceuticals Ltd, Novus Therapeutics, Inc, Pediapharm, Intas Pharmaceuticals Ltd., Sound Pharmaceuticals, Merz Pharma, Amneal Pharmaceuticals LLC., Zydus Pharmaceuticals, Inc, Mylan N.V., Alcon, F. Hoffmann-La Roche Ltd and many others.

The global otitis drug market is expected to grow at a substantial CAGR in the forecast period of 2019-2026 Vulnerable pediatric population as age related ear infections prone to develop otitis and prevalence of otitis population is the key factors to encourage the market growth.

Request Sample of Global Otitis Drug Market Report 2019 @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-otitis-drug-market

Global Otitis Drug Market By Type (Acute Otitis Media, Otitis Media with Effusion and Chronic Otitis Media with Effusion), Treatment Type (Medication and Surgery), Mechanism of Action Types (Corticosteroid, Topoisomerase Enzymes Type II Inhibitor, Cephalosporin Antibiotic and Anti-Infective), Route of Administration (Oral, Topical and Injectable),  End-Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Market Definition: 

Otitis is an inflammation of middle ear which results in dysfunction of Eustachian tube that occurs during a viral upper respiratory tract infection. Eustachian tube links the middle ear with the throat area and prevents drainage of fluid from the middle ear, causing a buildup of fluid behind the eardrum. When this fluid cannot evacuate, it allows for the infections to grow in the ear that can lead to acute otitis media.

According to the article published in American Academy of Family Physicians, it is estimated approximately 80% of children to be diagnosed with one episode of acute otitis media (AOM).  Exposure to certain toxin or change in environment may increase the otitis infections and prevalence of inflammatory disease of middle ear which acts as a key factor for market growth.

Market Drivers

  • Ongoing clinical trial studies being carried out by many pharmaceuticals industries
  • Exposure to certain toxin or change in environment may increase the otitis infections
  • Prevalence of indoor as well as outdoor allergens
  • Increase in prevalence rate of otitis disease worldwide

Market Restraints

  • Effective treatment is either unavailable or unaffordable
  • Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth if the market
  • Inadequate knowledge about tinnitus disease in some developing countries

Enquire for customization in Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-otitis-drug-market

Segmentation: 

By Type

  • Acute Otitis Media
  • Otitis Media with Effusion
  • Chronic Otitis Media with Effusion

By Treatment Type

  • Medication
  • Surgery

By Mechanism of Action Type

  • Corticosteroid
    • Ciprofloxacin And Dexamethasone
  • Topoisomerase Enzymes Type II Inhibitor
    • Finafloxacin Otic Suspension
  • Cephalosporin Antibiotic
    • Ceftriaxone Sodium
    • Ceftibuten
  • Anti-Infective
    • Ofloxacin Otic Solution

By Route of Administration

  • Oral
  • Topical
  • Injectable

 By End Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • Italy
    • U.K.
    • France
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Turkey
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Rest of South America
  • Middle East and Africa
    • South Africa
    • Rest of Middle East and Africa

Key Developments in the Market:

In February 2019,Novus Therapeutics, Inc, a specialty otolaryngology pharmaceutical company has initiated phase II trial for OP0201, a drug-device combination of surfactant dipalmitoylphosphatidylcholine and cholesteryl palmitate previously demonstrated a promising results for the treatment of otitis media in phase I trial clinical studies. If successful, it will represent a new and significant treatment option for otitis.

In March 2018, Otonomy, Inc received the FDA approval for OTIPRIO, (ciprofloxacin otic suspension) for the treatment of acute otitis externa in pediatric patients. OTIPRIO is the first single-dose antibacterial approved by the FDA for the treatment of acute otitis externa. With this approval it significantly expands the company’s product portfolio in the therapeutic area of Otolaryngology.

Competitive Analysis:

Global otitis drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

  • Current and future of global otitis drug market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

View Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-otitis-drug-market